Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
Stroke
|
January 20, 2007
Albumin-induced hematocrit-lowering and B-type natriuretic peptide increase
Antonio Muscari, Marco Zoli
International Journal of Cardiology
|
September 6, 2003
Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression?
Paolo Puddu, Giovanni M Puddu, Antonio Muscari
Cardiology
|
June 22, 2002
Lipid-lowering drugs: are adverse effects predictable and reversible?
Antonio Muscari, Giovanni M Puddu, Paolo Puddu
Acta Cardiologica
|
November 9, 2004
Different effects of antihypertensive drugs on endothelial dysfunction
Paolo Puddu, Giovanni Maria Puddu, Eleonora Cravero, et al.
World Journal of Gastroenterology
|
October 14, 2009
Carotid lesions in outpatients with nonalcoholic fatty liver disease
Stefano Ramilli, Stefano Pretolani, Antonio Muscari, et al.
Journal of Cardiology
|
March 9, 2012
Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications
Paolo Puddu, Giovanni M Puddu, Eleonora Cravero, et al.
Acta Cardiologica
|
July 5, 2007
The genetic basis of essential hypertension
Paolo Puddu, Giovanni Maria Puddu, Eleonora Cravero, et al.
Cardiology
|
January 25, 2005
Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis
Paolo Puddu, Giovanni M Puddu, Livia Galletti, et al.
The Canadian Journal of Cardiology
|
April 14, 2010
The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases
Paolo Puddu, Giovanni M Puddu, Eleonora Cravero, et al.
Cardiology
|
September 14, 2006
Gene-based therapy for hypertension--do preclinical data suggest a promising future?
Giovanni Maria Puddu, Eleonora Cravero, Eleonora Ferrari, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
Stroke
|
January 20, 2007
Albumin-induced hematocrit-lowering and B-type natriuretic peptide increase
Antonio Muscari, Marco Zoli
International Journal of Cardiology
|
September 6, 2003
Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression?
Paolo Puddu, Giovanni M Puddu, Antonio Muscari
Cardiology
|
June 22, 2002
Lipid-lowering drugs: are adverse effects predictable and reversible?
Antonio Muscari, Giovanni M Puddu, Paolo Puddu
Acta Cardiologica
|
November 9, 2004
Different effects of antihypertensive drugs on endothelial dysfunction
Paolo Puddu, Giovanni Maria Puddu, Eleonora Cravero, et al.
World Journal of Gastroenterology
|
October 14, 2009
Carotid lesions in outpatients with nonalcoholic fatty liver disease
Stefano Ramilli, Stefano Pretolani, Antonio Muscari, et al.
Journal of Cardiology
|
March 9, 2012
Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications
Paolo Puddu, Giovanni M Puddu, Eleonora Cravero, et al.
Acta Cardiologica
|
July 5, 2007
The genetic basis of essential hypertension
Paolo Puddu, Giovanni Maria Puddu, Eleonora Cravero, et al.
Cardiology
|
January 25, 2005
Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis
Paolo Puddu, Giovanni M Puddu, Livia Galletti, et al.
The Canadian Journal of Cardiology
|
April 14, 2010
The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases
Paolo Puddu, Giovanni M Puddu, Eleonora Cravero, et al.
Cardiology
|
September 14, 2006
Gene-based therapy for hypertension--do preclinical data suggest a promising future?
Giovanni Maria Puddu, Eleonora Cravero, Eleonora Ferrari, et al.
Page
of 6